6
Table 3. Recommended Candidates for the Initiation of
Inpatient Continuous Glucose Monitoring
• Those with impaired awareness of hypoglycemia
• Persons 65 years of age and older
• Persons with a body mass index (BMI) of 27 kg/m
2
or less
• Those with type 1 diabetes, who often have variable glycemic control
• Those requiring high-dose steroids or tapering off of steroids
• Those requiring parenteral nutrition or enteral nutrition who may be at risk for
hypoglycemia if the dietary source of glucose is discontinued/changed
• Those isolated for a contagious disease (e.g., COVID-19), as CGM may assist
with reducing health care personnel exposure and the need for personal protective
equipment
• Persons with chronic kidney disease (stages 3–5) and/or liver disease or critical
illness, given their higher propensity for hypoglycemia
• Persons with comorbid conditions that might increase their risk for hypoglycemia
including a history of cerebrovascular accident, active malignancy, congestive heart
failure, pancreatic disorders, or infection
• Those persons with a history of preadmission hypoglycemia or hypoglycemia
during recent/current admission
Treatment
Table 4. Elements Needed for Initiation of Continuous
Glucose Monitoring in the Inpatient Setting
• Engagement, training, and education of nursing personnel and other health care
providers
• Patient education regarding care of the device and how to respond to alerts for
high or low blood glucose (BG)
• Purchase of equipment (e.g., sensors, transmitters, receivers)
• Expertise from health care professionals knowledgeable in this technolog y
• Oversight and guidance for CGM use
• Integration of CGM data with the hospital electronic medical record
• Clarity of assigned responsibility for interpreting and acting on CGM data
Adapted from Galindo RJ, et al. J Diabetes Sci Technol, 2020; (14)4. © Diabetes Technolog y Society.
